United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Disposal of $5.26 Million in Common Shares

Bitget2026/10/21 20:37

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

United Therapeutics Chairperson and CEO Martine A. Rothblatt sold 9,500 common shares on October 20, 2026.
Reported weighted-average sale prices ranged from $546.8428 to $563.5646 per share.
Rothblatt also exercised 9,500 stock options at $117.76 per share, leaving 195,410 options held indirectly through a trust.
Following the transactions, the trust held 324,443 common shares; Rothblatt directly owned another 40,513 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000168), on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

United Therapeutics Chairperson and CEO Martine A. Rothblatt Reports Disposal of $5.26 Million in Common Shares

You may also like

Crypto prices